Published in Lab Business Week, September 25th, 2005
In a recent report, researchers in France conducted a study "To assess postmenopausal breast cancer risk in relation to particular patterns of oral contraceptive (OC) use according to hormone replacement therapy (HRT) exposure. Time-dependent Cox regression models were used to analyze information on postmenopausal women from a large-scale French cohort."
"Among a total of 68,670 women born between 1925 and 1950, 1405 primary invasive postmenopausal breast cancer cases were identified from 1992 to 2000," wrote V. Dumeaux and colleagues. "A non-significant...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Lab Business Week